-
1
-
-
79952528125
-
CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth
-
COI: 1:CAS:528:DC%2BC3MXjtFKisrY%3D, PID: 21397861
-
Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, Masuko T, Shimizu T, Ishikawa T, Kai K, Takahashi E, Imamura Y, Baba Y, Ohmura M, Suematsu M, Baba H, Saya H. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell. 2011;19(3):387–400.
-
(2011)
Cancer Cell
, vol.19
, Issue.3
, pp. 387-400
-
-
Ishimoto, T.1
Nagano, O.2
Yae, T.3
Tamada, M.4
Motohara, T.5
Oshima, H.6
Oshima, M.7
Ikeda, T.8
Asaba, R.9
Yagi, H.10
Masuko, T.11
Shimizu, T.12
Ishikawa, T.13
Kai, K.14
Takahashi, E.15
Imamura, Y.16
Baba, Y.17
Ohmura, M.18
Suematsu, M.19
Baba, H.20
Saya, H.21
more..
-
2
-
-
84875454018
-
xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma
-
COI: 1:CAS:528:DC%2BC3sXktVGisL0%3D, PID: 23319806
-
Yoshikawa M, Tsuchihashi K, Ishimoto T, Yae T, Motohara T, Sugihara E, Onishi N, Masuko T, Yoshizawa K, Kawashiri S, Mukai M, Asoda S, Kawana H, Nakagawa T, Saya H, Nagano O. xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Res. 2013;73(6):1855–66.
-
(2013)
Cancer Res
, vol.73
, Issue.6
, pp. 1855-1866
-
-
Yoshikawa, M.1
Tsuchihashi, K.2
Ishimoto, T.3
Yae, T.4
Motohara, T.5
Sugihara, E.6
Onishi, N.7
Masuko, T.8
Yoshizawa, K.9
Kawashiri, S.10
Mukai, M.11
Asoda, S.12
Kawana, H.13
Nakagawa, T.14
Saya, H.15
Nagano, O.16
-
3
-
-
0034772516
-
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug
-
COI: 1:CAS:528:DC%2BD3MXnvF2murs%3D, PID: 11587223
-
Gout PW, Buckley AR, Simms CR, Bruchovsky N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia. 2001;15(10):1633–40.
-
(2001)
Leukemia
, vol.15
, Issue.10
, pp. 1633-1640
-
-
Gout, P.W.1
Buckley, A.R.2
Simms, C.R.3
Bruchovsky, N.4
-
4
-
-
84949322403
-
Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc(-), leading to glutathione depletion
-
COI: 1:CAS:528:DC%2BC2MXkvFejtb8%3D, PID: 25798841
-
Sleire L, Skeie BS, Netland IA, Førde HE, Dodoo E, Selheim F, Leiss L, Heggdal JI, Pedersen PH, Wang J, Enger PØ. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc(-), leading to glutathione depletion. Oncogene. 2015;34(49):5951–9.
-
(2015)
Oncogene
, vol.34
, Issue.49
, pp. 5951-5959
-
-
Sleire, L.1
Skeie, B.S.2
Netland, I.A.3
Førde, H.E.4
Dodoo, E.5
Selheim, F.6
Leiss, L.7
Heggdal, J.I.8
Pedersen, P.H.9
Wang, J.10
Enger, P.Ø.11
-
5
-
-
84940467392
-
Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism
-
COI: 1:CAS:528:DC%2BC2MXht12kur%2FN, PID: 26254540
-
Ma MZ, Chen G, Wang P, Lu WH, Zhu CF, Song M, Yang J, Wen S, Xu RH, Hu Y, Huang P. Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism. Cancer Lett. 2015;368(1):88–96.
-
(2015)
Cancer Lett
, vol.368
, Issue.1
, pp. 88-96
-
-
Ma, M.Z.1
Chen, G.2
Wang, P.3
Lu, W.H.4
Zhu, C.F.5
Song, M.6
Yang, J.7
Wen, S.8
Xu, R.H.9
Hu, Y.10
Huang, P.11
-
6
-
-
84898721879
-
Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11
-
COI: 1:CAS:528:DC%2BC2cXls1ehs78%3D, PID: 24516043
-
Drayton RM, Dudziec E, Peter S, Bertz S, Hartmann A, Bryant HE, Catto JW. Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11. Clin Cancer Res. 2014;20(7):1990–2000.
-
(2014)
Clin Cancer Res
, vol.20
, Issue.7
, pp. 1990-2000
-
-
Drayton, R.M.1
Dudziec, E.2
Peter, S.3
Bertz, S.4
Hartmann, A.5
Bryant, H.E.6
Catto, J.W.7
-
7
-
-
33846628923
-
Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy
-
COI: 1:CAS:528:DC%2BD2sXitlWqurs%3D, PID: 17075799
-
Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR, Wang YZ. Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate. 2007;67(2):162–71.
-
(2007)
Prostate
, vol.67
, Issue.2
, pp. 162-171
-
-
Doxsee, D.W.1
Gout, P.W.2
Kurita, T.3
Lo, M.4
Buckley, A.R.5
Wang, Y.6
Xue, H.7
Karp, C.M.8
Cutz, J.C.9
Cunha, G.R.10
Wang, Y.Z.11
-
8
-
-
84884975764
-
Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia
-
COI: 1:CAS:528:DC%2BC3sXhsFOgs7rP, PID: 23848514
-
Wada T, Ishimoto T, Seishima R, Tsuchihashi K, Yoshikawa M, Oshima H, Oshima M, Masuko T, Wright NA, Furuhashi S, Hirashima K, Baba H, Kitagawa Y, Saya H, Nagano O. Functional role of CD44v-xCT system in the development of spasmolytic polypeptide-expressing metaplasia. Cancer Sci. 2013;104(10):1323–9.
-
(2013)
Cancer Sci
, vol.104
, Issue.10
, pp. 1323-1329
-
-
Wada, T.1
Ishimoto, T.2
Seishima, R.3
Tsuchihashi, K.4
Yoshikawa, M.5
Oshima, H.6
Oshima, M.7
Masuko, T.8
Wright, N.A.9
Furuhashi, S.10
Hirashima, K.11
Baba, H.12
Kitagawa, Y.13
Saya, H.14
Nagano, O.15
-
9
-
-
65449149109
-
Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer
-
COI: 1:CAS:528:DC%2BD1MXmtFeltro%3D, PID: 19189306
-
Palapattu GS, Wu C, Silvers CR, Martin HB, Williams K, Salamone L, Bushnell T, Huang LS, Yang Q, Huang J. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer. Prostate. 2009;69(7):787–98.
-
(2009)
Prostate
, vol.69
, Issue.7
, pp. 787-798
-
-
Palapattu, G.S.1
Wu, C.2
Silvers, C.R.3
Martin, H.B.4
Williams, K.5
Salamone, L.6
Bushnell, T.7
Huang, L.S.8
Yang, Q.9
Huang, J.10
-
10
-
-
84962180633
-
Sulfasalazine (SSZ) works cancer stem-like cells (CSCs) via inhibiting xCT signal pathway: phase 1 study in patients with gastric cancer (EPOC 1205)
-
Shitara K, Takahashi S, Nakajima T, Hironaka S, Nagano O, Imamura C, Mushiroda T, Einaga Y, Fukunani M, Sato A, Ohtsu A, Saya H, Doi T. Sulfasalazine (SSZ) works cancer stem-like cells (CSCs) via inhibiting xCT signal pathway: phase 1 study in patients with gastric cancer (EPOC 1205). Cancer Res. 2014;74:211.
-
(2014)
Cancer Res
, vol.74
, pp. 211
-
-
Shitara, K.1
Takahashi, S.2
Nakajima, T.3
Hironaka, S.4
Nagano, O.5
Imamura, C.6
Mushiroda, T.7
Einaga, Y.8
Fukunani, M.9
Sato, A.10
Ohtsu, A.11
Saya, H.12
Doi, T.13
|